Medpace Holdings Inc (MEDP)
Cash conversion cycle
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Days of inventory on hand (DOH) | days | — | — | — | — | — |
Days of sales outstanding (DSO) | days | 57.81 | 60.88 | 59.42 | 63.42 | 66.04 |
Number of days of payables | days | 7.63 | 10.38 | 10.10 | 12.97 | 11.27 |
Cash conversion cycle | days | 50.18 | 50.49 | 49.32 | 50.45 | 54.76 |
December 31, 2023 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= — + 57.81 – 7.63
= 50.18
The cash conversion cycle of Medpace Holdings Inc has seen fluctuations over the past five years. It increased from 52.70 days in 2019 to 51.60 days in 2022 before slightly decreasing to 49.21 days in 2023. A lower cash conversion cycle indicates that the company is able to convert its investments in inventory to cash more quickly.
The company's efficiency in managing its working capital has slightly improved over the years, as evidenced by the declining trend in the cash conversion cycle since 2022. This could be due to better inventory management, quicker collection of receivables, or more efficient payment of payables.
Overall, a decreasing trend in the cash conversion cycle is generally considered positive, as it signifies improved liquidity and operational efficiency. However, it's important to monitor this metric continuously to ensure sustainable working capital management practices.
Peer comparison
Dec 31, 2023